These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35121006)

  • 1. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Moschini M; Gandaglia G; Dehò F; Salonia A; Briganti A; Montorsi F
    Ann Oncol; 2022 May; 33(5):561. PubMed ID: 35121006
    [No Abstract]   [Full Text] [Related]  

  • 2. Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.
    Bellmunt J; Orsola A; Leow JJ; Wiegel T; De Santis M; Horwich A;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii40-8. PubMed ID: 25096609
    [No Abstract]   [Full Text] [Related]  

  • 3. [S3 guideline for bladder cancer : Claim and reality - a critical commentary from the guideline coordinators].
    Retz M; Maisch P; Gschwend JE
    Urologe A; 2016 Sep; 55(9):1188-91. PubMed ID: 27581238
    [No Abstract]   [Full Text] [Related]  

  • 4. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Bellmunt J; Orsola A; Wiegel T; Guix M; De Santis M; Kataja V;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi45-9. PubMed ID: 21908503
    [No Abstract]   [Full Text] [Related]  

  • 5. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
    Horwich A; Babjuk M; Bellmunt J; Bruins HM; De Reijke TM; De Santis M; Gillessen S; James N; Maclennan S; Palou J; Powles T; Ribal MJ; Shariat SF; Van Der Kwast T; Xylinas E; Agarwal N; Arends T; Bamias A; Birtle A; Black PC; Bochner BH; Bolla M; Boormans JL; Bossi A; Briganti A; Brummelhuis I; Burger M; Castellano D; Cathomas R; Chiti A; Choudhury A; Compérat E; Crabb S; Culine S; De Bari B; DeBlok W; De Visschere PJL; Decaestecker K; Dimitropoulos K; Dominguez-Escrig JL; Fanti S; Fonteyne V; Frydenberg M; Futterer JJ; Gakis G; Geavlete B; Gontero P; Grubmüller B; Hafeez S; Hansel DE; Hartmann A; Hayne D; Henry AM; Hernandez V; Herr H; Herrmann K; Hoskin P; Huguet J; Jereczek-Fossa BA; Jones R; Kamat AM; Khoo V; Kiltie AE; Krege S; Ladoire S; Lara PC; Leliveld A; Linares-Espinós E; Løgager V; Lorch A; Loriot Y; Meijer R; Carmen Mir M; Moschini M; Mostafid H; Müller AC; Müller CR; N'Dow J; Necchi A; Neuzillet Y; Oddens JR; Oldenburg J; Osanto S; Oyen WJG; Pacheco-Figueiredo L; Pappot H; Patel MI; Pieters BR; Plass K; Remzi M; Retz M; Richenberg J; Rink M; Roghmann F; Rosenberg JE; Rouprêt M; Rouvière O; Salembier C; Salminen A; Sargos P; Sengupta S; Sherif A; Smeenk RJ; Smits A; Stenzl A; Thalmann GN; Tombal B; Turkbey B; Vahr Lauridsen S; Valdagni R; Van Der Heijden AG; Van Poppel H; Vartolomei MD; Veskimäe E; Vilaseca A; Vives Rivera FA; Wiegel T; Wiklund P; Williams A; Zigeuner R; Witjes JA
    Ann Oncol; 2019 Nov; 30(11):1697-1727. PubMed ID: 31740927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Bellmunt J; Albiol S; Kataja V;
    Ann Oncol; 2009 May; 20 Suppl 4():79-80. PubMed ID: 19454472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Short version of the German S3 guideline for bladder cancer].
    Retz M; Gschwend JE; Maisch P
    Urologe A; 2016 Sep; 55(9):1173-87. PubMed ID: 27495910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.
    Bellmunt J; Orsola A; Maldonado X; Kataja V;
    Ann Oncol; 2010 May; 21 Suppl 5():v134-6. PubMed ID: 20555063
    [No Abstract]   [Full Text] [Related]  

  • 9. Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Bellmunt J; Albiol S; Kataja V;
    Ann Oncol; 2008 May; 19 Suppl 2():ii47-8. PubMed ID: 18456766
    [No Abstract]   [Full Text] [Related]  

  • 10. [CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer].
    Gnjidić M; Vojnović Ž; Čonkaš M; Čabo FG; Belev B; Budisavljević A; Gilja I; Plavetić ND; Šeparović R; Vrbanec D
    Lijec Vjesn; 2016; 138(7-8):167-72. PubMed ID: 30091881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia.
    Tan WS; Rodney S; Lamb B; Feneley M; Kelly J
    Cancer Treat Rev; 2016 Jun; 47():22-31. PubMed ID: 27231966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey.
    Witjes JA; Melissen DO; Kiemeney LA
    Eur Urol; 2006 Mar; 49(3):478-84. PubMed ID: 16406242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International consensus for advanced bladder cancer: an opportunity between the lines.
    Murthy V
    Ann Oncol; 2019 Nov; 30(11):1688-1690. PubMed ID: 31750878
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations for the diagnosis, treatment, and follow-up of cancer of the bladder].
    Lobel B; Abbou CC; Brausi MA; Flanigan RC; Kameyama S; Scher HI; Caffrey JM; Tachibana M
    Prog Urol; 1998 Sep; 8(4):590-2. PubMed ID: 9834529
    [No Abstract]   [Full Text] [Related]  

  • 15. Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer.
    Nishiyama H
    Jpn J Clin Oncol; 2018 Jan; 48(1):3-6. PubMed ID: 29145591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.
    Matulay JT; Tabayoyong W; Duplisea JJ; Chang C; Daneshmand S; Gore JL; Holzbeierlein JM; Karsh LI; Kim SP; Konety BR; Li R; McKiernan JM; Messing EM; Steinberg GD; Williams SB; Kamat AM
    Urol Oncol; 2020 Oct; 38(10):796.e1-796.e6. PubMed ID: 32430255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Powles T; Bellmunt J; Comperat E; De Santis M; Huddart R; Loriot Y; Necchi A; Valderrama BP; Ravaud A; Shariat SF; Szabados B; van der Heijden MS; Gillessen S;
    Ann Oncol; 2022 Mar; 33(3):244-258. PubMed ID: 34861372
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
    Maisch P; Retz M; Gschwend JE; Koll F; Schmid SC
    Urol Int; 2021; 105(1-2):31-40. PubMed ID: 32829338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.
    Kubota Y; Nakaigawa N;
    Int J Urol; 2016 Aug; 23(8):640-5. PubMed ID: 27374472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: A systematic review.
    Mori K; Miura N; Babjuk M; Karakiewicz PI; Mostafaei H; Laukhtina E; Quhal F; Motlagh RS; Pradere B; Kimura S; Egawa S; Shariat SF
    Urol Oncol; 2020 Oct; 38(10):774-782. PubMed ID: 32654948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.